Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleEntrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).AuthorsDesai, Ami V; Robinson, Giles W; Gauvain, Karen; Basu, Ellen M; Macy, Margaret E; Maese, Luke; Whipple, Nicholas S; Sabnis, Amit J; Foster, Jennifer H; Shusterman, Suzanne; Yoon, Janet; Weiss, Brian D; Abdelbaki, Mohamed S; Armstrong, Amy E; Cash, Thomas; Pratilas, Christine A; Corradini, Nadège; Marshall, Lynley V; Farid-Kapadia, Mufiza; Chohan, SaibahPublicationNeuro-Oncology, 2022, Vol 24, p1776ISSN1522-8517Publication typeArticleDOI10.1093/neuonc/noac087